comparemela.com

Latest Breaking News On - முக்கியமான பாதை நிறுவனம் - Page 3 : comparemela.com

People in Action

People in Action
insidetucsonbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidetucsonbusiness.com Daily Mail and Mail on Sunday newspapers.

Launch of UNITE4TB partnership marks a new era in tuberculosis treatment development

Launch of UNITE4TB partnership marks a new era in tuberculosis treatment development
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board

Share this article TUCSON, Ariz., May 19, 2021 /PRNewswire/   Critical Path Institute (C-Path) today announced the appointment of Robert M. Califf, MD, MACC, head of Clinical Policy and Strategy for Google parent company Alphabet s Verily Life Sciences and Google Health divisions, to C-Path s Board of Directors. Califf served as the U.S. Food and Drug Administration (FDA) Commissioner under President Barack Obama s administration from 2016-2017. Robert M. Califf, MD, MACC A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

C-Path announces accelerated data sharing collaboration with Tufts Medical Center

C-Path and Tufts Medical Center have announced a joint venture to integrate the first patient-level clinical trial data to generate actionable real-world evidence for neonatal drug development, from real-world neonate data. This activity, funded by the FDA, is being executed through a neonatal pilot project within C-Path s International Neonatal Consortium.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.